Feb-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
The cannabis brand 1906 has shown a remarkable consistency in the Capsules category across several states, maintaining the top rank in Illinois, Massachusetts, Missouri, New Jersey, and New York from November 2025 to February 2026. This dominance in the Capsules category is a testament to the brand's strong market presence and consumer preference in these regions. However, while the brand holds the number one position, it's worth noting that there has been a steady decline in sales figures over these months, particularly in Illinois and Massachusetts, where sales dropped by approximately 23% and 47% respectively from November 2025 to February 2026.
In contrast, the performance of 1906 in the Edible category in New York reveals a different narrative. The brand's ranking slipped from 25th in November 2025 to 32nd by February 2026, indicating a competitive and challenging market environment. Despite this drop in ranking, the sales figures for edibles have shown resilience, with a slight increase from January to February 2026. This suggests that while 1906 may not be among the top contenders in the Edible category, there is still a consistent demand for their products, hinting at potential growth opportunities if strategic adjustments are made.
Competitive Landscape
In the New York capsules category, 1906 has consistently maintained its top rank from November 2025 through February 2026, showcasing its dominance in the market. Despite a gradual decline in sales over these months, 1906's position remains unchallenged, indicating strong brand loyalty and market presence. In contrast, Level has held the second position consistently, with sales figures significantly lower than those of 1906. This stability in ranking for both brands suggests a clear market segmentation where 1906 leads with a substantial margin, while Level remains a distant competitor. The data highlights 1906's ability to retain its leadership position despite fluctuations in sales, underscoring the brand's resilience and strategic market positioning in the New York capsules sector.

Notable Products
In February 2026, the top-performing product for 1906 was Boost Drops Pills 20-Pack (100mg), which climbed to the number one spot with sales figures reaching 9,951. The CBD/THC 1:1 Bliss Tablets 20-Pack (100mg CBD, 100mg THC) slipped to second place, maintaining strong sales but showing a slight decrease from previous months. The CBD/THC 5:1 Chill Tablets 20-Pack (500mg CBD, 100mg THC) held steady in third place, although its sales continued to decline. The CBD/THC/CBN 2:2:1 Sleep for ZZZ'S Drops 20-Pack (100mg CBD, 100mg THC, 40mg CBN) remained fourth, consistent with its January ranking. Lastly, the CBD/THC 1:1 Go Drop Tablets 20-Pack (100mg CBD, 100mg THC) stayed in fifth place, reflecting a steady performance despite decreasing sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







